Literature DB >> 16882990

Effects of mutation at the D-JH junction on affinity, specificity, and idiotypy of anti-progesterone antibody DB3.

Mingyue He1, Maureen Hamon, Hong Liu, Adam L Corper, Michael J Taussig.   

Abstract

The crystal structures of the Fab' fragment of the anti-progesterone monoclonal antibody DB3 and its complexes with steroid haptens have shown that the D-JH junctional residue TrpH100 is a key contributor to binding site interactions with ligands. The indole group of TrpH100 also undergoes a significant conformational change between the bound and unliganded states, effectively opening and closing the combining site pocket. In order to explore the effect of substitutions at this position on steroid recognition, we have carried out mutagenesis on a construct encoding a three-domain single-chain fragment (VH/K) of DB3 expressed in Escherichia coli. TrpH100 was replaced by 13 different amino acids or deleted, and the functional and antigenic properties of the mutated fragments were analyzed. Most substitutions, including small, hydrophobic, hydrophilic, neutral, and negatively charged side chains, were reduced or abolished binding to free progesterone, although binding to progesterone-BSA was partially retained. The reduction in antigen binding was paralleled by alteration of the idiotype associated with the DB3 combining site. In contrast, the replacement of TrpH100 by Arg produced a mutant that retained wild-type antibody affinity and idiotype, but with altered specificity. Significant changes in this mutant included increased relative affinities of 10(4)-fold for progesterone-3-carboxymethyloxime and 10-fold for aetiocholanolone. Our results demonstrate an essential role for the junctional residue H100 in determining steroid-binding specificity and combining site idiotype and show that these properties can be changed by a single amino acid substitution at this position.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882990      PMCID: PMC2242612          DOI: 10.1110/ps.062236806

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

1.  Evolution of shape complementarity and catalytic efficiency from a primordial antibody template.

Authors:  J Xu; Q Deng; J Chen; K N Houk; J Bartek; D Hilvert; I A Wilson
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

2.  A single H:CDR3 residue in the anti-digoxin antibody 26-10 modulates specificity for C16-substituted digoxin analogs.

Authors:  M K Short; P D Jeffrey; A Demirjian; M N Margolies
Journal:  Protein Eng       Date:  2001-04

3.  Modulation of antibody display on M13 filamentous phage.

Authors:  J A Chappel; M He; A S Kang
Journal:  J Immunol Methods       Date:  1998-12-01       Impact factor: 2.303

4.  The "megaprimer" method of site-directed mutagenesis.

Authors:  G Sarkar; S S Sommer
Journal:  Biotechniques       Date:  1990-04       Impact factor: 1.993

5.  Progesterone monoclonal antibody blocks pregnancy in mice.

Authors:  L J Wright; A Feinstein; R B Heap; J C Saunders; R C Bennett; M Y Wang
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

6.  Energetic analysis of binding of progesterone and 5 beta-androstane-3,17-dione to anti-progesterone antibody DB3 using molecular dynamics and free energy calculations.

Authors:  M Peräkylä; N Nordman
Journal:  Protein Eng       Date:  2001-10

7.  Complementary combining site contact residue mutations of the anti-digoxin Fab 26-10 permit high affinity wild-type binding.

Authors:  Mary K Short; Rustem A Krykbaev; Philip D Jeffrey; Michael N Margolies
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

8.  Efficacy and specificity of monoclonal antibodies to progesterone in preventing the establishment of pregnancy in the mouse.

Authors:  S T Ellis; R B Heap; A R Butchart; V Rider; N E Richardson; M W Wang; M J Taussig
Journal:  J Endocrinol       Date:  1988-07       Impact factor: 4.286

9.  Anti-idiotypic sera against monoclonal anti-progesterone antibodies: production in rabbits and rats and characterization of specificity.

Authors:  M J Taussig; N Brown; S Ellis; A Holliman; D Peat; N Richardson; R B Heap; A Feinstein
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

10.  Analysis of an anti-progesterone antibody: variable crystal morphology of the Fab' and steroid-Fab' complexes.

Authors:  E A Stura; J H Arevalo; A Feinstein; R B Heap; M J Taussig; I A Wilson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

View more
  4 in total

1.  Site-directed mutations of anti-amantadine scFv antibody by molecular dynamics simulation: prediction and validation.

Authors:  Sanlei Xie; Jianyi Wang; Xuezhi Yu; Tao Peng; Kai Yao; Sihan Wang; Demei Liang; Yuebin Ke; Zhanhui Wang; Haiyang Jiang
Journal:  J Mol Model       Date:  2020-02-04       Impact factor: 1.810

2.  Bacterial expression and characterization of a novel human anti-IgE scFv fragment.

Authors:  MingRong Wang; YongXia Zhang; TianFei Du; YunJian Dai; YongZhi He; Xin Yu; Cong Cong; MingYue He
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Closely related antibody receptors exploit fundamentally different strategies for steroid recognition.

Authors:  Petra Verdino; Caroline Aldag; Donald Hilvert; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

4.  Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.

Authors:  Joerg U Schmohl; Deborah Todhunter; Seung Oh; Daniel A Vallera
Journal:  Toxins (Basel)       Date:  2015-10-10       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.